GARLAND JAMES: Open Payments
NPI 1255968434 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,685 in 251 payments from 23 companies in 2025. Trend: 2023 $12,368 · 2024 $28,361 · 2025 $29,685
Speaker / faculty: $13,388Consulting: $8,280Food & beverage: $5,878Travel & lodging: $1,964Education: $176
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 47 | $21,501 |
| Eli Lilly and Company | 5 | $3,440 |
| GENZYME CORPORATION | 15 | $587 |
| Regeneron Healthcare Solutions, Inc. | 14 | $581 |
| ABBVIE INC. | 40 | $579 |
| Incyte Corporation | 23 | $572 |
| UCB, Inc. | 13 | $419 |
| Janssen Biotech, Inc. | 15 | $351 |
| PFIZER INC. | 22 | $320 |
| Arcutis Biotherapeutics, Inc. | 16 | $259 |
Products named: ANZUPGO, ADBRY, EBGLYSS, DUPIXENT, OPZELURA, TREMFYA, Bimzelx, CIBINQO.
Industry payments across MD — which companies pay providers there.
